New York, February 3 (FinanceEnquiry.com) - Analyst Kenneth Leon of S&P Capital IQ upgrades the shares of CME Group (NYSE: CME) from BUY to STRONG BUY. The target price has been raised from $323 to $320.

In a research note published this morning, the analyst mentions that the company is poised to benefit from an anticipated upturn in US economy and a rebound in capital markets from the late 2011 weakness. CME has the most attractive mix of new sources of growth and core trading products, as compared to its peers, the analyst says. The MF Global overhang is more of a risk to market confidence than a negative to CME’s future exchanges, the analyst says. Being well capitalized, CME has declared a special dividend of $3 per share, in addition to its regular dividend, S&P Capital IQ adds.